Biomarker

indicator of a biological state or condition

Commentary Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
May 18 2016
Want to Really Speed up Cancer Research? Start Sharing More Data.
By Tom Coburn, Dr. Daniel P. Petrylak Read time 4 mins Read More
Commentary Health, Health, Health FDA Reform, Pharmaceuticals, Pharmaceuticals
Nov 06 2015
Why the FDA Rejected a Drug That Cures Lung Cancer — And What We Can Do to Fix It
By Paul Howard Read time 8 mins Read More
Commentary Health FDA Reform, Pharmaceuticals
Aug 19 2015
How Can Policymakers Bridge the Gap Between Precision Medicine and FDA Regulation?
By Peter W. Huber, Paul Howard Read time 1 mins Read More
Testimony Health FDA Reform, Pharmaceuticals
Jul 14 2015
Testimony by Peter Huber Before the Senate Subcommittee on Space, Science and Competitiveness
By Peter W. Huber Read time 27 mins Read More
Commentary Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
Jul 09 2015
21st Century Cures Is Good Health (And Fiscal) Policy
By Yevgeniy Feyman, Paul Howard Read time 4 mins Read More
Commentary Health, Health FDA Reform, Pharmaceuticals
Apr 13 2015
Is Pharmaceutical Productivity In Decline? Maybe Not
By Yevgeniy Feyman Read time 5 mins Read More
Report Health FDA Reform, Pharmaceuticals
Mar 11 2015
Unlocking the Code of Health Bridging the Gap Between Precision Medicine and FDA Regulation
By Peter W. Huber, Paul Howard Read time 10 mins Read More
Press Release Health Pharmaceuticals
Mar 11 2015
New Report: How To Make Precision Medicine A Reality
Read time 1 mins Read More
Commentary Health, Health, Tech, Cities FDA Reform, Pharmaceuticals, Technology, New York City, Energy
Mar 05 2014
Overcoming 20th-Century Regulations To Allow 21st-Century Cures
By Peter W. Huber Read time 22 mins Read More
Commentary Health
Feb 24 2014
Beyond Obamacare: Focus On Cures, Not Costs (Part 2)
By Yevgeniy Feyman Read time 7 mins Read More